J Michael Carroll - Net Worth and Insider Trading
J Michael Carroll Net Worth
The estimated net worth of J Michael Carroll is at least $1 dollars as of 2025-07-23. J Michael Carroll is the Director of Chanticleer Holdings Inc and owns about 3 shares of Chanticleer Holdings Inc (BURG) stock worth over $1. Details can be seen in J Michael Carroll's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that J Michael Carroll has not made any transactions after 2016-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of J Michael Carroll
J Michael Carroll Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Michael Carroll owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of J Michael Carroll’s form 4 insider trades.
Insider Ownership Summary of J Michael Carroll
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2005-06-27 | director |
J Michael Carroll Latest Holdings Summary
J Michael Carroll currently owns a total of 1 stock. J Michael Carroll owns 3 shares of Chanticleer Holdings Inc (BURG) as of September 23, 2016, with a value of $1.
Latest Holdings of J Michael Carroll
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BURG | Chanticleer Holdings Inc | 2016-09-23 | 3 | 0.34 | 1 |
Holding Weightings of J Michael Carroll
J Michael Carroll Form 4 Trading Tracker
According to the SEC Form 4 filings, J Michael Carroll has made a total of 0 transactions in Chanticleer Holdings Inc (BURG) over the past 5 years. The most-recent trade in Chanticleer Holdings Inc is the acquisition of 1 shares on September 23, 2016, which cost J Michael Carroll around $2,520.
Insider Trading History of J Michael Carroll
- 1
J Michael Carroll Trading Performance
GuruFocus tracks the stock performance after each of J Michael Carroll's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Michael Carroll is -33.82%. GuruFocus also compares J Michael Carroll's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Michael Carroll within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Michael Carroll's insider trading performs compared to the benchmark.
Performance of J Michael Carroll
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -28.56 | | | | | |
| Relative Return to S&P 500(%) | -27.47 | | | | | |
J Michael Carroll Ownership Network
Ownership Network List of J Michael Carroll
Ownership Network Relation of J Michael Carroll
J Michael Carroll Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
J Michael Carroll is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
J Michael Carroll Mailing Address
Above is the net worth, insider trading, and ownership report for J Michael Carroll. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, J Michael Carroll's mailing address is: Richmond Va 23233-2222.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
